The Evidence Based Rheumatology Podcast

The Evidence Based Rheumatology Podcast header image 1

Entries from April 2018

E19: Clinical Utility of a Positive ANA

April 29th, 2018 · Comments

Quick podcast this week on the utility of an ANA.  It's a frequent reason for referral (17% in this series) to rheumatology offices and this is a useful paper for context. Find the paper itself here.

Tags: DefaultTag

E18: Triple Therapy for Catastrophic Antiphospholipid Syndrome

April 22nd, 2018 · Comments

A recent retrospective study on a rare condition - catastrophic antiphospholipid syndrome - caught my eye in the Journal of Rheumatology this week.  I thought it would be a good opportunity to talk about unmeasured confounding and introduce a rare condition that new fellows need to know about.  Find the paper itself here

Tags: DefaultTag

E17: Steroids and the Risk of Scleroderma Renal Crisis

April 15th, 2018 · Comments

Short but impactful paper this week on the association between steroids and scleroderma renal crisis.  Find the original paper here.

Tags: DefaultTag

E16: Tocilizumab in Giant-Cell Arteritis - GIACTA

April 8th, 2018 · Comments

Getting back to our usual format, this week we'll discuss the GIACTA trial, which compared various schedules of tocilizumab to various schedules of placebo and prednisone.  It's an important trial that has changed the face of GCA and will be a refreshing RCT to discuss before we dive back into garbagey data next week.  

Tags: DefaultTag

E15: The Ribosomal P Isn’t Useful in NPSLE

April 1st, 2018 · Comments

Welcome back! This week we're doing something a little different and discussing a few important studies on the ribosomal P in neuropsychiatric SLE.  We also have theme music!  Let me know what you think about both on twitter @EBRheum. 

Tags: DefaultTag

Play this podcast on Podbean App